Chemoinformaics analysis of Violarvensin
Molecular Weight | 578.523 | nRot | 4 |
Heavy Atom Molecular Weight | 548.283 | nRig | 30 |
Exact Molecular Weight | 578.164 | nRing | 5 |
Solubility: LogS | -3.076 | nHRing | 3 |
Solubility: LogP | -0.494 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 2 |
nHetero | 14 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 14 | No. of Arom Bond | 17 |
nHA | 14 | APOL | 76.3218 |
nHD | 10 | BPOL | 36.1722 |
QED | 0.172 |
Synth | 4.823 |
Natural Product Likeliness | 1.831 |
NR-PPAR-gamma | 0.951 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.965 |
HIA | 0.97 |
CACO-2 | -6.3 |
MDCK | 0.0000485 |
BBB | 0.151 |
PPB | 0.764165 |
VDSS | 0.929 |
FU | 0.138694 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.021 |
CYP2c19-inh | 0.004 |
CYP2c19-sub | 0.064 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.517 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.142 |
CYP3a4-inh | 0.003 |
CYP3a4-sub | 0.003 |
CL | 1.169 |
T12 | 0.226 |
hERG | 0.015 |
Ames | 0.699 |
ROA | 0.319 |
SkinSen | 0.034 |
Carcinogencity | 0.036 |
EI | 0.004 |
Respiratory | 0.016 |
NR-Aromatase | 0.957 |
Antiviral | Yes |
Prediction | 0.841339 |